Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs FFIV✓SelectedUSD · FFIVGSK vs FFIV performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs FFIV

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.4%
FFIV return
+30.3%
Excess return
+16.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioFFIVExcessAlpha
1D-0.1%-1.4%+1.4%0.0%
7D-1.3%-4.1%+2.8%-1.1%
30D+2.7%-31.1%+33.8%+4.7%
3M+2.7%-24.4%+27.1%+4.1%
6M+3.3%-16.0%+19.3%+3.8%
YTD+6.5%+19.4%-12.9%+3.8%
1Y+10.7%+30.2%-19.5%+6.9%
3Y+64.4%+89.2%-24.8%+48.0%
All+46.4%+30.3%+16.1%+33.4%

Cumulative growth

Daily Returns

Daily percentage return beside FFIV.

Daily Out/Under-Performance

Portfolio return minus FFIV return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × FFIV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded FFIV wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling